The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

After approval, tirzepatide dispensations increased markedly among adults with type 2 diabetes prescribed glucose-lowering ...

The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published ...

Investigators say Lewis Family Care’s weight loss clinic earned nearly $250,000 from administering the unapproved drug.

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

A Kentucky physician is facing up to three years in prison after distributing non-FDA approved semaglutide drugs, prosecutors ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain following bariatric surgery, a Swiss real-world study reveals.

The U.S. Food and Drug Administration (FDA) has warned consumers not to use counterfeit Ozempic (semaglutide) found ...

Healthcare professionals and patients have been told to check their prescription are legitimate after the FDA seized the fake semaglutide drug. | ITV National News ...

For many they are a miracle drug helping individuals lose weight for the first time in years, but the long term effects of so-called weight loss drugs remain to be seen ...